SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

DRREDDYS LABORATORIES

BSE: 500124 18 Aug 2025
Healthcare
₹ 1258.2
Dr. Reddy's Laboratories Ltd., specializes in Pharmaceuticals within the Healthcare sector.

DRREDDYS LABORATORIES - Share Price & Details

Market Cap
₹1,05,095
High /Low
1,421 / 1,020
Stock P/E
18.6
Book Value
₹402.0
Dividend Yield
0.62
ROCE
22.7
ROE
₹18.0
Face Value
1.0
PEG Ratio
0.49
EVEBITDA
₹10.9
Debt
4,677
CMP / FCF
43.5
Debt to equity
₹0.14
NP Ann
5,725
High price all time
1,421
Piotroski score
₹2.0
Graham Number
785.0
No. Eq. Shares
83.5
Net CF
₹749
Net profit
5,743
Price to book value
3.13
Interest Coverage
₹26.2
Low price all time
60.5
Industry PE
33.1
Reserves
₹33,466
Free Cash Flow
₹1,327

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
Shyama Computronics and Servic1.480.930.670.005.3335.5
Triochem Products Ltd.,3.25-4.52NA-18.440
DR.REDDYS LABORATORIES LTD.88624.014099.085721.017.021,05,09518.6
Mankind Pharma Limited26055.84127.625413.69.9910205154.0
Zydus Lifesciences Limited27454.03847.025883.03.829847021.1

Peer Comparison Chart


About DRREDDYS LABORATORIES

Dr. Reddy's Laboratories Ltd.,, with Security Code 500124, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Dr Reddy's Secures CDSCO Panel Approval to Import, Market Olutasidenib for AML

(17 Aug 2025)
New Delhi: In a significant development, the pharmaceutical major, Dr. Reddy's Laboratories, has got the go-ahead from the Subject Expert...
Read more →

DRREDDY Outlook for the Week (August 18, 2025 – August 22, 2025)

(15 Aug 2025)
Technically, Dr Reddys Laboratories share price will see immediate support at 1,221.00 and immediate resistance would be seen at 1,282.90.
Read more →

AIA Group Ltd Sells 101,293 Shares of Dr. Reddy's Laboratories Ltd (NYSE:RDY)

(14 Aug 2025)
AIA Group Ltd decreased its position in Dr. Reddy's Laboratories Ltd (NYSE:RDY - Free Report) by 69.8% during the first quarter,...
Read more →

Dr Reddys Laboratories Ltd spurts 2.42%, rises for fifth straight session

(13 Aug 2025)
Dr Reddys Laboratories Ltd is quoting at Rs 1249.8, up 2.42% on the day as on 12:44 IST on the NSE. The stock is down 8.12% in last one year...
Read more →

Natixis Advisors LLC Trims Stock Position in Dr. Reddy's Laboratories Ltd (NYSE:RDY)

(13 Aug 2025)
Natixis Advisors LLC cut its stake in Dr. Reddy's Laboratories Ltd (NYSE:RDY - Free Report) by 53.3% in the first quarter, according to the...
Read more →

Dr. Reddy's, Aurobindo face a near-'lost' opportunity for an important pipeline drug; Here's why

(12 Aug 2025)
Among Indian generics makers, Iron Sucrose had been considered a key pipeline product for Dr. Reddy's Laboratories and Aurobindo Pharma.
Read more →

Company Updates